|
Tuesday 9th September 2008 |
Text too small? |
The company placed 33 million shares at 10 cents apiece with New Zealand institutions, it said in a statement. All up since July, it has raised the equivalent of half its market value by selling shares.
The stock was unchanged at 11 cents yesterday on the NZAX market and has dropped 50% this year.
The company's net loss widened to NZ$6.3 million last year from NZ$5.1 million. Revenue tumbled 67% after A2 ended trading at its Australian subsidiary and began trading to a 50%-owned joint venture.
A2 Corp was started in 2000 to commercialise milk with high levels of A2 beta casein protein. A number of studies associate with potential benefits in some individuals, according to the company's website.
The company entered into business and licensing partnerships to bring A2 milk to the market in New Zealand, Australia, Korea and the US.
No comments yet
A2 Corp's Babidge, Mair take advantage of soaring price to sell 6M shares
A2 shares touch record-high as investors buy into growth story
A2 FY profit slips on cost of setting up UK joint venture, sales jump 51 percent as Australian shines
A2 first-half profit dented by UK joint venture, affirms annual earnings target of $11.2M
A2 to raise $20M in placement, big shareholders sell down
A2 Corp mulls capital structure in face of growth opportunities
A2 Corp, in talks to move to main board, halts shares pending statement
A2 in talks with NZX about shifting to main board
A2 Corp to take control of NZ marketing; enter North America, Europe
A2 Corp talks up Chinese infant formula market potential
